本页面由Tiger Trade Technology Pte. Ltd.提供服务

Tango Therapeutics Inc.

22.85
-1.3250-5.48%
成交量:174.68万
成交额:4,052.38万
市值:38.61亿
市盈率:-27.20
高:24.11
开:24.11
低:22.81
收:24.17
52周最高:34.39
52周最低:6.69
股本:1.69亿
流通股本:1.21亿
量比:0.96
换手率:1.44%
股息:- -
股息率:- -
每股收益(TTM):-0.8400
每股收益(LYR):-0.8746
净资产收益率:-21.34%
总资产收益率:-12.99%
市净率:3.77
市盈率(LYR):-26.12

数据加载中...

2022/08/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/07/11

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/06/10

重要事件披露

8-K - Current report
2022/05/11

重要事件披露

8-K - Current report
2022/05/11

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/03/28

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/28

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/28

重要事件披露

8-K - Current report
2022/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/04

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/11/09

重要事件披露

8-K - Current report
2021/11/09

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/10/14

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/09/27

SEC问询函

CORRESP [Cover] - Correspondence
2021/09/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/09/10

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2021/08/20

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/08/19

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership